Aquestive Therapeutics Quote - AQST

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

3.085

Bid

3.08

Ask

3.09

Volume

634,312

3.04 Day's Range 3.14

2.24 52 Week Range 6.23

Market Cap

281.285M

Previous Close

3.09

Open

3.10

Last Trade

3.085

Last Trade Time

12:15:24

Financial Volume

US$ 1,950,134

VWAP

3.0744

Average Volume (3m)

1,616,848

Shares Outstanding

91,178,193

Dividend Yield

PE Ratio

-35.81

Earnings Per Share (EPS)

-0.09

Revenue

50.58M

Net Profit

-7.87M

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the t... Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aquestive.com

Headquarters

Wilmington, Delaware, USA

Founded

Aquestive Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AQST. The last closing price for Aquestive Therapeutics was US$3.09. Over the last year, Aquestive Therapeutics shares have traded in a share price range of US$ 2.24 to US$ 6.23.

Aquestive Therapeutics currently has 91,178,193 shares outstanding. The market capitalization of Aquestive Therapeutics is US$281.74 million. Aquestive Therapeutics has a price to earnings ratio (PE ratio) of -35.81.

Form 8-K - Current report

Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives

On track to submit Anaphylm™ (epinephrine) Sublingual Film NDA in Q1 2025Actively recruiting subjects in the Anaphylm pediatric clinical trialSuccessfully completed AQST-108 (epinephrine) Topical...

Form 8-K - Current report

Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five

WARREN, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful...

Form 8-K - Current report

Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm™ (epinephrine) Sublingual Film

Reaffirms New Drug Application (NDA) first quarter 2025 submission guidanceConfirms no additional adult clinical trials are necessary prior to NDA submission Commenced pediatric trial in the U.S...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.005	-0.161812297735	3.09	3.3	2.96	1455668	3.10746018	CS
4	-0.475	-13.3426966292	3.56	3.79	2.96	1491787	3.33236286	CS
12	-2.475	-44.5143884892	5.56	5.8	2.96	1616848	4.26168858	CS
26	0.085	2.83333333333	3	5.8	2.92	1437739	4.29336527	CS
52	0.475	18.1992337165	2.61	6.23	2.24	1700555	4.01781608	CS
156	-0.565	-15.4794520548	3.65	6.23	0.618	896312	3.10620149	CS
260	-1.055	-25.4830917874	4.14	9.465	0.618	845597	3.86915298	CS

AQST - Frequently Asked Questions (FAQ)

What is the current Aquestive Therapeutics share price?

The current share price of Aquestive Therapeutics is US$ 3.085

How many Aquestive Therapeutics shares are in issue?

Aquestive Therapeutics has 91,178,193 shares in issue

What is the market cap of Aquestive Therapeutics?

The market capitalisation of Aquestive Therapeutics is USD 281.74M

What is the 1 year trading range for Aquestive Therapeutics share price?

Aquestive Therapeutics has traded in the range of US$ 2.24 to US$ 6.23 during the past year

What is the PE ratio of Aquestive Therapeutics?

The price to earnings ratio of Aquestive Therapeutics is -35.81

What is the cash to sales ratio of Aquestive Therapeutics?

The cash to sales ratio of Aquestive Therapeutics is 5.57

What is the reporting currency for Aquestive Therapeutics?

Aquestive Therapeutics reports financial results in USD

What is the latest annual turnover for Aquestive Therapeutics?

The latest annual turnover of Aquestive Therapeutics is USD 50.58M

What is the latest annual profit for Aquestive Therapeutics?

The latest annual profit of Aquestive Therapeutics is USD -7.87M

What is the registered address of Aquestive Therapeutics?

The registered address for Aquestive Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Aquestive Therapeutics website address?

The website address for Aquestive Therapeutics is www.aquestive.com

Which industry sector does Aquestive Therapeutics operate in?

Aquestive Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDMDBaird Medical Investment Holdings Ltd	US$ 9.4734 (74.79%)	15.75M
BTCTBTC Digital Ltd	US$ 7.4213 (55.91%)	23.99M
NUKKNukkleus Inc	US$ 31.12 (51.58%)	16.99M
CRKNCrown Electrokinetics Corporation	US$ 0.120098 (50.69%)	400.4M
GSITGSI Technology	US$ 4.02 (46.18%)	74.97M
PMAXPowell Max Ltd	US$ 0.641 (-22.75%)	2.89M
LGCBLinkage Global Inc	US$ 0.2978 (-19.51%)	600.09k
SHOTWSafety Shot Inc	US$ 0.1855 (-17.56%)	3.36k
BLRXBioLineRx Ltd	US$ 0.1007 (-17.39%)	22.44M
AENTAlliance Entertainment Holding Corporation	US$ 4.91 (-17.34%)	129.03k
GCTKGlucoTrack Inc	US$ 0.0935 (26.69%)	422.88M
CRKNCrown Electrokinetics Corporation	US$ 0.120098 (50.69%)	400.4M
TGLTreasure Global Inc	US$ 0.279 (30.19%)	251.52M
RIMEAlgorhythm Holdings Inc	US$ 0.0428 (1.18%)	249.4M
NVDANVIDIA Corporation	US$ 138.12 (3.41%)	120.91M